Literature DB >> 31067365

Collateral Benefits of Preventive Chemotherapy - Expanding the War on Neglected Tropical Diseases.

Peter J Hotez1, Alan Fenwick1, David H Molyneux1.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31067365     DOI: 10.1056/NEJMp1900400

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  New global targets for NTDs in the WHO roadmap 2021-2030.

Authors:  Adriano Casulli
Journal:  PLoS Negl Trop Dis       Date:  2021-05-13

2.  The history of the neglected tropical disease movement.

Authors:  David H Molyneux; Anarfi Asamoa-Bah; Alan Fenwick; Lorenzo Savioli; Peter Hotez
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-01-28       Impact factor: 2.184

Review 3.  Maximising Societal Benefit From the Control of Neglected Zoonoses: Identifying Synergies and Trade-Offs in the Control of Taenia solium.

Authors:  Cristina Soare; Amelia Garcia-Ara; Alessandro Seguino; Matthys Uys; Lian F Thomas
Journal:  Front Vet Sci       Date:  2022-02-09

4.  Elevated Pediatric Chagas Disease Burden Complicated by Concomitant Intestinal Parasites and Malnutrition in El Salvador.

Authors:  Melissa S Nolan; Kristy O Murray; Rojelio Mejia; Peter J Hotez; Maria Jose Villar Mondragon; Stanley Rodriguez; Jose Ricardo Palacios; William Ernesto Murcia Contreras; M Katie Lynn; Myriam E Torres; Maria Carlota Monroy Escobar
Journal:  Trop Med Infect Dis       Date:  2021-05-07

5.  Central Latin America: Two decades of challenges in neglected tropical disease control.

Authors:  Peter J Hotez; Ashish Damania; Maria Elena Bottazzi
Journal:  PLoS Negl Trop Dis       Date:  2020-03-26

6.  Comparison of real-time PCR and the Kato-Katz method for the diagnosis of soil-transmitted helminthiasis and assessment of cure in a randomized controlled trial.

Authors:  Beatrice Barda; Christian Schindler; Rahel Wampfler; Shaali Ame; Said M Ali; Jennifer Keiser
Journal:  BMC Microbiol       Date:  2020-10-02       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.